It is critical that nurse leaders, including chief nurse executives and service line directors, be part of the institutional decision-making process about resource allocation, strategic direction, and planning for the future. Nurse leaders can use numerous strategies to influence decisions made in the boardroom that affect the women's service line, including perinatal and women's health. These strategies include building on the importance of women's services to the organization, working in collaboration with senior leaders and key physician leaders, marketing, and reaching out to governing boards with information. Nurse leaders must continue to prepare for the future to thrive in the increasingly complex health care environment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0884217504265091 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Student perceptions of repeating a nursing fundamentals course: A qualitative descriptive study.
Nursing
December 2024
At the York College of Pennsylvania, Jenna Davis is an assistant professor. She serves as the course coordinator for the Basic Principles course and teaches in the NCLEX support course. Carrie Pucino is an associate professor at York College of Pennsylvania. She has served as a leader in developing and improving the York College NCLEX Preparation Program, revising and teaching in the NCLEX support course, and providing one-to-one NCLEX coaching for high-risk students.
Purpose: To explore perceptions of student learning in undergraduate nursing students who repeat the fundamentals nursing course and simultaneously take a support course.
Methods: This qualitative descriptive design was conducted at one private liberal arts college. The study included interviews with six undergraduate baccalaureate nursing students repeating the fundamentals course and their perceptions following the repeated course.
Aims: To understand the current capacity and capability for nursing, midwifery and allied health professional (NMAHP) principal investigator roles in England.
Design: Quantitative online survey.
Methods: Online national quantitative survey across England analysed using descriptive statistics.
Public Health.
Alzheimers Dement
December 2024
University of Southern California, Los Angeles, CA, USA.
Background: The lack of inclusion of Latinos/Hispanics in Alzheimer's disease and related dementias (ADRD) clinical trials reduces the generalizability of study findings and hinders our understanding of the mechanisms of dementia, further widening cognitive health disparities. To address this growing public health concern, the purpose of this study is to leverage the national infrastructure of a Consortium between the National Association of Hispanic Nurses (NAHN) and the Alzheimer's Association (ALZ) to increase the representation Latino/Hispanic participants in one clinical trial on dementia.
Methods: The study used a randomized controlled trial design and mixed-method evaluation.
Public Health.
Alzheimers Dement
December 2024
Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Background: Ethnic and racial diversity in clinical research is critical for developing generalizable treatments and caregiving strategies. Barriers to participation among persons from underrepresented groups (URG) are systemic in clinical research. To increase URG research participation, we designed a community-based data collection site where study participants complete full research visits.
View Article and Find Full Text PDFPublic Health.
Alzheimers Dement
December 2024
Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, CA, USA.
Background: Alzheimer's disease (AD) disproportionately affects minoritized populations, who are consistently underrepresented in clinical trials. We aimed to recruit underrepresented adults aged 55-80 to an ongoing preclinical AD trial.
Method: A community-based strategy was used to recruit Filipino, Hispanic/Latino, and Korean adults into the AHEAD study, a preclinical AD trial testing the anti-amyloid treatment lecanemab, at the University of California, Irvine.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!